PCR

Scientists Enabling Scientists®

Established in 1976, Enzo focused on developing innovative products and services for improving human healthcare through basic research, drug development, and patient care. Enzo remains at the forefront of target amplification technologies critical in the detection of infectious agents, cancer markers, and genotyping, which opened the door for many of the well-known molecular diagnostics assays in use today.

Our molecular platforms and quality critical reagents enabled rapid response to the SARS-CoV-2 pandemic. And we incorporate our flexibility and quality-focus to our customers by offering customized products and services for large-scale and long-term projects. 

Advanced AMPIGENE® PCR Solutions to cover your workflow

AMPIGENE® PCR products use the latest
polymerase technology and buffer chemistry to
improve PCR performance.

• From Sample Extraction to Analysis Extraction to Analysis
• Suitable for unprocessed sample
• Custom and bulk options available

AMPIPROBE® Nucleic Acid Detection

AMPIPROBE® incorporates Enzo’s proprietary primer design in a unique qPCR platform that enables sensitive detection of nucleic acids. A low-cost alternative in a price-sensitive market, AMPIPROBE® assay kits are designed for clinically relevant targets. Enzo’s landmark AMPIPROBE® assay, the AMPIPROBE® HCV assay kit, is a sensitive qPCR assay to measure Hepatitis C viral load.

• RT-qPCR
• Incorporates probe detection technology in primer design
  • Fluorescent reporter-labeled primers
  • Quencher-labeled primers
• Enzo’s AMPIPROBE® Assay Kits provide the following benefits:
  • Compatible with open qPCR platforms
  • Smaller sample input allows remaining extracted samples to be used in other tests
  • Smaller reaction volume consumes less reagents